facebook-page-view
Advertisement

Eris Lifesciences Ltd

Eris Lifesciences to buy Samara-backed Oaknet Healthcare

Healthcare

04 May, 2022

Eris Lifesciences to buy Samara-backed Oaknet Healthcare

Eris Lifesciences Ltd on Wednesday said it will acquire private equity firm Samara Capital-backed pharma platform Oaknet Healthcare Pvt Ltd ......

Premium
Kuwait's sovereign fund bets on ChrysCap-backed drugmaker

Healthcare

29 September, 2020

Kuwait's sovereign fund bets on ChrysCap-backed drugmaker

Kuwait Investment Authority has purchased stock in a pharmaceuticals company where homeomegrown private equity firm ChrysCapital had returned to invest ......

Premium
ChrysCapital pumps more money into healthcare portfolio firm

Healthcare

27 March, 2020

ChrysCapital pumps more money into healthcare portfolio firm

Homegrown private equity firm ChrysCapital has increased its exposure to a pharmaceutical company in which it re-entered as an investor ......

Premium
ChrysCapital injects more funds into drugmaker after returning as investor

Healthcare

25 February, 2020

ChrysCapital injects more funds into drugmaker after returning as investor

Homegrown private equity firm ChrysCapital has pumped additional capital into a pharmaceutical company, barely weeks after coming on board again ......

Premium
ChrysCapital returns as investor in another pharma firm after taking it public

Healthcare

03 February, 2020

ChrysCapital returns as investor in another pharma firm after taking it public

Homegrown private equity firm ChrysCapital has returned to invest in a pharmaceutical company that it had helped launch on the ......

Cipla acquires India trademark rights for anti-diabetic drug from Novartis

Healthcare

16 December, 2019

Cipla acquires India trademark rights for anti-diabetic drug from Novartis

Indian pharmaceutical major Cipla Ltd has acquired the brand name and trademark rights for Vysov and Vysov M (Vildagliptin and ......

Eris Lifesciences buys anti-diabetic drug from Novartis for India market

Healthcare

04 December, 2019

Eris Lifesciences buys anti-diabetic drug from Novartis for India market

Eris Lifesciences Ltd said it has acquired the trademark for anti-diabetic drug Zomelis for $13 million (Rs 92.9 crore) from ......

Indian IPO markets have become deeper: NSE Tech Conclave

Finance

27 February, 2018

Indian IPO markets have become deeper: NSE Tech Conclave

Indian primary capital markets have become deeper and have proved to be an attractive exit mechanism for private equity and ......

Eris Lifesciences to buy Strides Shasun's India generics biz for $77 mn

Healthcare

18 November, 2017

Eris Lifesciences to buy Strides Shasun's India generics biz for $77 mn

Eris Lifesciences Ltd has agreed to acquire Strides Shasun Ltd’s branded generics business in India for Rs 500 crore ($77 ......

Eris Lifesciences acquires nutraceuticals maker UTH Healthcare

Healthcare

03 October, 2017

Eris Lifesciences acquires nutraceuticals maker UTH Healthcare

Drugmaker Eris Lifesciences Ltd has acquired nutraceuticals maker UTH Healthcare Ltd for Rs 12.85 crore ($1.96 million) in cash.Eris said ......